Generics Greg Perry, director general of the European Generic medicines Association (EGA) opened the 9th edition of the EGA Scientific and Regulatory Affairs Conference held recently in London, UK, by reiterating the association's vision to create an improved European regulatory framework for generic and biosimilar medicines. Entitled Vision 2015, the plan aims to meet three main objectives: create a globally competitive generic industry, increase patient access to affordable quality medicines and ensure sustainable healthcare in Europe. 1 February 2010